Please provide your email address to receive an email when new articles are posted on . Genitourinary syndrome of menopause is common but often underrecognized in dermatology. Low-dose vaginal ...

A Pap smear result indicating cervical dysplasia may actually be an early signal of genitourinary syndrome (vaginal atrophy) and can be treated effectively with local estrogen, according to a poster ...

The physiological aging process and menopause with low estrogen levels can negatively change the urogenital system. Vaginal atrophy secondary to a decline in estrogen, involves thinning of the vaginal ...

Vaginal estrogens, vaginal dehydroepiandrosterone (DHEA), and oral ospemifene can improve vulvovaginal dryness and dyspareunia associated with genitourinary syndrome of menopause (GSM), according to a ...

CHICAGO--(BUSINESS WIRE)--Dr. Lauren Streicher, a leading gynecologist and menopause expert, addresses the widespread issue of genitourinary syndrome of menopause (GSM) in her latest podcast episode.

Please provide your email address to receive an email when new articles are posted on . Oral lasofoxifene was associated with improvement in bothersome vaginal symptoms, vaginal pH and vaginal ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

In women with an intact uterus: moderate-to-severe vasomotor symptoms of menopause; moderate-to-severe vulvar and vaginal atrophy associated with menopause. Angeliq combines the estrogen, estradiol, ...

LJUBLJANA, Slovenia, Aug. 27, 2019 /CNW/ -- In an industry first achievement, Fotona's Dynamis Laser System received clearance by Health Canada, Canada's Food and Drugs Act and Regulations Agency, to ...

Genitourinary syndrome of menopause, urinary incontinence or vagina laxity can imply serious problems in terms of Women's quality of life and sexual health. Nowadays, beyond creams, moisturizers and ...

As women age, they are more susceptible to vaginal dryness and pain during intercourse because of vulvovaginal atrophy (VVA). A new study suggests that ospemifene and systemic hormone therapy both ...